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The transcription factor signal transducer and activator of transcription 3 (STAT3) is an important mediator of the inﬂammatory
process. We investigated the role of STAT3 in viral myocarditis and its possible role in the development to dilated cardiomyopathy.
We used STAT3-deﬁcent mice with a cardiomyocyte-restricted knockout and induced a viral myocarditis using Coxsackievirus B3
(CVB3) which induced a severe inﬂammation during the acute phase of the viral myocarditis. A complete virus clearance and an
attenuated inﬂammation were examined in both groups WT and STAT3 KO mice 4 weeks after infection, but the cardiac function
inSTAT3KOmicewassigniﬁcantlydecreasedincontrasttotheinfectedWTmice.Interestingly,anincreasedexpressionofcollagen
I was detected in STAT3 KO mice compared to WT mice 4 weeks after CVB3 infection. Furthermore, the matrix degradation was
reducedinSTAT3KOmicewhichmightbeanexplanationfortheobservedmatrixdeposition.Consequently,weheredemonstrate
the protective function of STAT3 in CVB3-induced myocarditis. Since the cardiomyocyte-restricted knockout leads to an increased
ﬁbrosis, it can be assumed that STAT3 signalling in cardiomyocytes protects the heart against increased ﬁbrosis through paracrine
eﬀects.
1.Introduction
Acute viral myocarditis is a frequent cause of sudden cardiac
death and can later progress to dilated cardiomyopathy
(DCM) due to the chronic inﬂammatory process. On the
one hand, the inﬂammatory process is needed to control
the acute viral infection, but, on the other hand, prolonged
inﬂammation in the subacute phase of the disease will lead
to adverse cardiac remodelling. This is mainly characterised
with an accumulation of cardiac collagen as well as a
deregulation of matrix metalloproteinases, known to be
important for collagen degradation and for modulating
the inﬂammatory process [1, 2]. Despite our growing
knowledge about viral myocarditis, it remains challenging to
diagnose and especially treat patients with viral myocarditis
[3, 4]. Therefore, we need to understand more about the
inﬂammatory process in the acute phase of viral myocarditis
to tailor future treatment strategies to limit the progression
to DCM.
One of the potent regulators of inﬂammation is the
signal transducer and activator of transcription 3 (STAT3)
which is activated in response to extracellular proteins such
as cytokines. The members of the IL-6-type cytokine family
bind to plasma membrane receptor complexes containing
the signal transducing 130kDa glycoprotein (gp130) that are
ubiquitously expressed in most tissues including the heart.
Ligand binding to this receptor subsequently leads to the
phosphorylation of STAT3 which is then translocated into
the nucleus [5]. This family of cytokines is named after the
prominent member IL-6 which leads to an increased phos-
phorylation of STAT3 [6]. Several studies have implicated
that STAT3 is essential for hypertrophy and cytoprotection
in the heart [7–9]. While its role in acute viral myocarditis
is still unknown, it is interesting that the signalling via2 Cardiology Research and Practice
the gp130/STAT3 pathway is profoundly altered in the
myocardium of patients with DCM [10]. It was observed
that IL-6 expression as well as STAT3 phosphorylation
was decreased in the myocardium of patients with DCM.
Interestingly, the myocardial IL-6 expression decreases,
whereas the circulating level of IL-6 was increased in patients
with heart failure [11, 12]. Moreover, several experimental
studieshavebeenperformedwithacardiomyocyte-restricted
knockout of STAT3 [13]. In general, the cardiomyocyte-
restrictedSTAT3KOleadstoanage-inducedﬁbrosis.Beyond
9 months, the STAT3 KO mice show increased interstitial
ﬁbrosis, and, at 12 months, the hearts were dilated [14, 15],
suggesting a role for STAT3 in cardiac remodelling and the
progression to DCM.
Here, we study the eﬀect of cardiomyocyte-restricted
knockout of STAT3 in viral myocarditis to evaluate its role
during inﬂammation as well as adverse cardiac remodelling
in experimental viral myocarditis.
2.MaterialandMethods
2.1. Study Design. Mice with the cardiomyocyte-restricted
STAT3 deletion were generated on a CB6FI genetic back-
groundasdescribedpreviously[14]andkeptunderstandard
conditions. Male STAT3 KO and WT animals were infected
with 106 plaque-forming units of CVB3 intraperitoneally
(all mice were 6 weeks old at the day of infection). Infected
mice were compared with saline-treated mice of both groups
10 and 28 days after infection. This investigation conforms
to the Guide for the Care and Use of Laboratory Animals
published by the US NIH (NIH Publication number 85-23,
revised 1996).
2.2. Hemodynamic Measurements and Surgical Procedures.
Four weeks after infection with CVB3, all animals were
anesthetized (thiopental 125mg/g i.p.), intubated, and artiﬁ-
ciallyventilated. A 1.2 F-mircoconductance pressure catheter
(SciSence,Ontario,Canada)waspositionedintheleftventri-
cle via the right carotid artery for continuous registration of
pressure-volume loops in a closed-chest model as described
previously [16].
Global function was quantiﬁed by heart rate (bpm),
cardiac output (mL/min), stroke volume (μL), stroke work
(μL · mmHg), and ejection fraction (%). Systolic function
was assessed by end systolic pressure, Pes (mmHg), left
ventricular contractility dP/dtmax (mmHg/s), and end sys-
tolic volume Ves (μL). Diastolic performance was measured
by end diastolic pressure Ped (mmHg), left ventricular
relaxation dP/dtmin (mmHg/s), left ventricular relaxation
time Tau (ms), and end diastolic volume Ved (μL).
Hearts of sacriﬁced animals were removed and immedi-
ately frozen in liquid nitrogen and stored at −80◦C for later
biological or immunohistochemical analyses.
2.3. RNA Isolation and Gene Expression Analysis. Frozen
tissue sections were minced in Trizol and further disrupted
during 10 minutes of vigorous shaking. To extract the
RNA, chlorophorm was added, mixed, and centrifuged.
The aqueous phase containing the RNA was collected in a
separate tube, and isopropanol was added. For precipitation,
the RNA solution was centrifuged 15 minutes at 4◦Ca t
high speed. The RNA pellet was then further puriﬁed using
the RNeasy Mini Kit (Qiagen) according to manufacturer’s
protocol. One μg of RNA was reverse transcribed into cDNA
using the High Capacity Kit (Applied Biosystems) and then
further diluted to a ﬁnal concentration of 5ng/μL cDNA.
T h er e l a t i v eq u a n t i ﬁ c a t i o no fm R N Al e v e l sw e r ec a r r i e d
out on a 7900 TaqMan systems (Applied Biosystem). To
assess the mRNA expression of the target genes, real-
time PCR was performed using 5μL of the gene expres-
sion master mix (Applied Biosystems) and 0.5μL of the
gene expression assay for IL-1β (Mm00434228 m1), IL-
6 (Mm00446190 m1), TNF-α (Mm00443258 m1), IL-
10 (Mm00439616 m1), TGF-β (Mm00441724 m1), ANF
(Mm01255747 g1), MMP13 (Mm00439491 m1), TIMP1
(Mm00441818 m1) (each includes forward and reverse
primers as well the ﬂuorescently FAM-labelled probe) from
Applied Biosystems, and 1μLo fc D N Ai naﬁ n a lv o l u m e
of 10μL. Quantiﬁcation of the house keeping gene 18S
(Hs99999901 s1) as an internal control was performed for
each sample. Data were normalized to 18S RNA level as an
endogenous control and are expressed using the formula
2−ΔΔCt in comparison to the corresponding untreated con-
trols. CVB3 copy numbers were detected using a forward
primer (CCCTGAATGCGGCTAATCC) and a reverse primer
(ATTGTCACCATAAGCAGCCA) in a ﬁnal concentration of
60ng/μL as well as a FAM-labelled MGB probe (FAM-
TGCAGCGGAACCG) in a ﬁnal concentration of 5pM.
2.4. Histological Measurements. Pieces of heart were either
embedded in Tissue-Tek or paraﬃn. Sections embedded
in Tissue-Tek were stained with antibodies directed against
CD3 (goat anti-CD3; Santa-Cruz), VCAM (rat anti-VCAM;
Pharmingen), collagen I (rabbit anti-ColI; Chemicon), and
collagen III (rabbit anti-ColIII; Calbiochem). The paraﬃn
sections were used for Mac3 staining using a speciﬁc anti-
body directed against Mac3 (rat anti-Mac3; Pharmingen).
For VCAM and Mac3 staining a biotinylated secondary
rabbit anit-rat antibody and for CD3 staining a biotinylated
secondary rabbit anti-goat antibody was used followed
by visualization with a biotin-streptavidin-peroxidase tech-
nique (Vectorlabs). For visualization of ColI and ColIII
staining, the Envision peroxidise technique was used (Dako).
2.5. In Situ Hybridization. Tissue sections from frozen hearts
28 days after CVB3 infection were used for detection of
viral RNA with a 35S-labelled CVB3-speciﬁc RNA probe
as described previously [17, 18]. Brieﬂy, hybridisation with
RNA probe proceeded at 42◦C for 18 hours. Slices were
then washed as described [18], and nonhybridized single-
strand RNA probes were digested by RNase A. Slices were
autoradiographed and stained with hematoxylin/eosin.
2.6. Statistical Analysis. Data are shown as mean ± SEM.
For comparison the nonparametric, Mann-Whitney U test
was used. Diﬀerences were considered signiﬁcant when theCardiology Research and Practice 3
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Figure 1: Cytokine expression levels in cardiac tissue of CVB3 infected mice. The mRNA expression levels are shown 10 and 28 days after
CVB3 infection of WT and STAT3 KO mice. The expression data are normalized to the house-keeping gene 18S and to the expression
levels of the corresponding untreated mice and expressed as x-fold over basal expression using the formula 2−ΔΔCt. ∗Data were compared to
the expression of the corresponding untreated controls. ∗P<0.05; ∗∗P<0.01. §Data between WT and STAT3 KO mice were compared.
§P<0.05.
probability value P is lower than 0.05. All analyses were
performed using Graph Pad Prism 5.0 software (GraphPad
Software, La Jolla, CA).
3. Results
3.1. Cytokine Expression after CVB3 Infection. To study
the cytokine response induced by intraperitoneal CVB3
infection, the mRNA expression levels in cardiac tissue of
infected and non infected WT and STAT3 KO mice were
analysed.
10 days after infection with CVB3 WT mice show a
signiﬁcantly increased mRNA expression level of the proin-
ﬂammatory cytokines IL-1β (15.92 ± 5.86 fold, P = 0.0043),
IL-6 (18.62 ± 8.89 fold, P = 0.0043), and TNF-α (8.85 ±
3.34 fold, P = 0.0043) compared to the expression level in
cardiac tissue of untreated WT mice. Whereas, 28 days after
CVB3infectionWTmiceshowaweakerbutstillsigniﬁcantly
increased mRNA expression level of IL-1β (3.75 ± 0.57,
P = 0.0195) and TNF-α (2.20 ± 0.21, P = 0.0430) compared
to the expression levels in untreated controls. A raised IL-
6 mRNA expression level could no longer be detected in
the CVB3-infected WT mice (Figure 1(a)—white bars). The
anti-inﬂammatory cytokines IL-10 (184.41 ± 90.69 fold,
P = 0.0357) and TGF-β (2.33 ± 0.37 fold, P = 0.0087) are
both signiﬁcantly increased 10 days after CVB3 infection,
whereas no raised mRNA expression was determined 28 days
after infection (Figure 1(b)—white bars).
In the cardiac tissue of infected STAT3 KO mice, the
mRNA expression of the proinﬂammatory cytokines IL-
1β (8.95 ± 3.00 fold, P = 0.0111), IL-6 (17.19 ± 5.39
fold, P = 0.0140), and TNF-α (4.39 ± 0.96, P =
0.0055) was signiﬁcantly increased 10 days after infection
compared to the expression levels in untreated STAT3 KO
mice. In contrast to the cytokine expression in WT mice,
the expression of IL-1β and TNF-α in STAT3 KO mice
was not longer raised 28 days after infection. However,
as already shown for infected WT mice, no increased
IL-6 expression was determined (Figure 1(a)—black bars).
The expression of the anti-inﬂammatory cytokine IL-10
(85.91 ±33.96 fold, P = 0.0357) was increased 10 days after
CVB3 infection and decreased to a normal expression level
28 days after infection. Interestingly, an augmented TGF-β4 Cardiology Research and Practice
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after CVB3 infection (Figure 1(b)—black bars).
Comparing the cytokine expression of infected WT mice
and infected STAT3 KO mice, only few diﬀerences were
obvious. Interestingly, in infected STAT3 KO mice, TGF-β
expression was not signiﬁcantly increased (1.50 ± 0.35 fold,
P = 0.2766) 10 days after infection, in contrast to the raised
expression level in infected WT mice (2.33 ± 0.37 fold, P =
0.0087) (Figure 1(b)). Additionally, the anti-inﬂammatory
cytokine IL-10, which is increased in both WT and STAT3
KO mice, is slightly but not signiﬁcantly weaker increased in
STAT3 KO mice 10 days after CVB3 infection.
3.2. Immune Cell Inﬁltration after CVB3 Infection. The
intraperitoneal CVB3 infection leads to a signiﬁcantly
increased inﬁltration of CD3+ and Mac3+ cells in cardiac
tissue of WT as well as STAT3 KO mice. In general, 10 days
after CVB3 infection, more inﬁltrated cells were determined
than 28 days after infection.
InWTmice,thenumberofinﬁltratedCD3+ (18.30±6.06
fold, P = 0.0043) and Mac3+ (31.19 ±9.02 fold, P = 0.0043)
cellsweresigniﬁcantlyincreased10daysafterCVB3infection
compared to the control animals. In comparison to the
inﬂammation occurring 10 days after infection, the number
of CD3+ cells was slightly but not signiﬁcantly decreased to
6.40±1.45fold(P = 0.0070)comparedtountreatedcontrols
28 days after infection. In contrast, the number of inﬁltrated
Mac3+ cells was strongly and signiﬁcantly (P = 0.0046)
reduced from 31.19 ± 9.02 fold 10 days after infection to
3.72 ± 1.29 fold (P = 0.028 compared to untreated controls)
28 days after infection (Figure 2—white bars).
In the cardiac tissue of infected STAT3 KO mice, a
signiﬁcantly increased number of CD3+ cells (14.48 ± 4.38
fold, P = 0.0003) was observed 10 days after CVB3 infection
which was signiﬁcantly reduced (P = 0.0379) to an 4.90 ±
1.03 fold increase (P = 0.0182) compared to untreated
controls 28 days after infection. In contrast, the number of
inﬁltrated Mac3+ cells 10 days after CVB3 infection (14.48 ±
4.86 fold, P = 0.0006) was slightly but not signiﬁcantly
reduced (8.86±2.12 fold, P = 0.0091) 28 days after infection
(Figure 2—black bars).
No diﬀerences were found comparing the number of
inﬁltrated CD3+ cells between WT and STAT3 KO mice.
Interestingly, the signiﬁcantly reduced inﬁltration of Mac3+
cells in cardiac tissue of CVB3-infected WT comparing day
10 and 28 after infection could not be demonstrated in the
cardiac tissue of infected STAT3 KO mice. There, the number
of Mac3+ cells was not signiﬁcantly decreased after 28 days
compared to 10 days. Even more Mac3+ cells were found in
cardiactissueofCVB3-infectedSTAT3KOmicecomparedto
CVB3-infected WT mice (WT: 3.72±1.29 fold versus STAT3
KO: 8.86 ±2.12 fold, P = 0.0232) 28 days after infection.
3.3. Virus Load and Clearance. Intraperitoneal CVB3 infec-
tionresultedinahighviralgenomequantity incardiactissue
of both infected groups 10 days after infection determined
by gene expression analysis. No viral genome was detected
in non infected control animals. No signiﬁcant diﬀerence
wasdeterminedinviralgenomequantitycomparinginfected
WT mice ((151 ± 88) × 103 copy numbers) and infected
STAT3 KO mice ((30 ± 18) × 103 copy numbers). Similarly,
28 days after infection, the copy number of viral genome in
infected WT mice (18 ± 10) and infected STAT3 KO mice
(16±5) revealed no diﬀerences. Therefore, a nearly complete
virus clearance was demonstrated for both WT and STAT3
KO mice 28 days after CVB3 infection. The complete virus
clearance was further conﬁrmed using in situ hybridisation
which stains virus replication with a radioactively labelled
CVB3-speciﬁcprobe.There,noviralgenomewasdetectedin
infected wild-type or STAT3 KO mice 28 days after infection.
3.4. Expression of Adhesion Molecule VCAM. The expression
of the vascular cell adhesion molecule VCAM was analysed
using cryosections of untreated and CVB3-infected WT
and STAT3 KO mice 28 days after infection. Whereas the
VCAM expression was not raised in infected WT mice
compared to their untreated controls (1.28 ± 0.46 fold, P =
0.5536), a signiﬁcant increase was determined in STAT3
KO mice (5.00 ± 1.38 fold, P = 0.0290). Therefore, the
signiﬁcantly higher VCAM expression in infected STAT3 KO
mice compared to infected WT mice was obvious (P =
0.0250) (Figure 3).
3.5. Hemodynamic Data. The infected WT and the infected
STAT3 KO mice were hemodynamically characterized 28
days after infection and compared to the hemodynamic
function of their respective non infected controls.
As shown in Table 1, the global function in infected
WT and infected STAT3 KO mice is restricted compared to
the respective controls. Both WT and STAT3 KO revealed a
signiﬁcantlyreducedcardiacoutputandstrokeworkinduced
by CVB3 infection. Furthermore, the ejection fraction is
signiﬁcantly reduced in infected STAT3 KO mice and slightly
butnotsigniﬁcantlyreducedininfectedWTmice.Moreover,
CVB3 infection resulted in impaired systolic and diastolic
function indicated by signiﬁcantly reduced Pes and dP/dtmax
aswellassigniﬁcantlyincreasedPed,dP/dtmin,andT auinWT
as well as in STAT3 KO mice.
Interestingly, compared to their respective controls,
infected STAT3 KO mice reveal a signiﬁcantly more impaired
global, systolic, and diastolic function. The ejection fraction
is reduced to 78% in infected WT animals and signiﬁ-
cantly more decreased to 57% in infected STAT3 KO mice.
Moreover, the end systolic pressure Pes was reduced to 87%
in infected WT and to 60% in infected STAT3 animals.
Furthermore, the end diastolic pressure Ped was 2.7-fold
higher in infected WT mice and even 5-fold increased
in infected STAT3 KO mice compared to their respective
controls.
3.6. ANF as Marker for Heart Failure. Since atrial natriuretic
factor (ANF) is known as a marker for heart failure, we
examined the mRNA expression level of ANF which was
higher expressed in cardiac tissue of infected WT (7.20±3.54
fold, P = 0.0823) and STAT3 KO (5.11 ± 1.18 fold, P =
0.0079) mice as in control animals. Interestingly, in infectedCardiology Research and Practice 5
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Figure 2: Cell inﬁltration in cardiac tissue 10 and 28 days after CVB3 infection. Data are expressed as area fraction of tissue sections after
staining with antibodies directed against CD3 or Mac3. Data were normalized to corresponding untreated controls and expressed as x-fold
over basal level. ∗Data were compared to the corresponding untreated controls. ∗P<0.05; ∗∗P<0.01; ∗∗∗P<0.001. §Data between WT
and STAT3 KO mice were compared. §P<0.05. #Data between 10 or 28 days were compared. #P<0.05; ##P<0.01.
WT mice, ANF expression was nearly reduced to the normal
expression level (2.72 ± 1.29 fold, P = 0.9371) 28 days
after infection. Whereas, the increased ANF expression level
remained unchanged in STAT3 KO mice (9.37 ± 2.62 fold,
P = 0.0476) and revealed a signiﬁcant higher expression
(P = 0.0160) of ANF in cardiac tissue of infected STAT3
KO mice compared to infected WT 28 days after infection
(Figure 4).6 Cardiology Research and Practice
Table 1: Animal characteristics and hemodynamic measurements 28 days after CVB3 infection.
WT WT-CVB3 STAT3 KO STAT3 KO-CVB3
Body weight [g] 29 ±22 3 ±12 8 ±12 2 ±1
H e a r tw e i g h t[ g ] 0 .15 ±0.03 0.09 ±0.01 0.11 ±0.01 0.09 ±0.01
Global function
Heart rate [bpm] 434 ±30 404 ±14 353 ±90 420 ±12
Cardiac output [mL/min] 15 ±11 1 ±1∗ 14 ±18 ±1∗†
Stroke volume [μL] 31 ±42 9 ±23 0 ±12 2 ±2
Stroke work [μL · mmHg] 3589 ±116 2384 ±117∗∗ 3331 ±173 1631 ±125∗††
Ejection fraction [%] 67 ±35 2 ±26 8 ±23 9 ±2∗∗††
Systolic function
Pes [mmHg] 123 ±6 100 ±1∗ 122 ±11 74 ±9∗†
dP/dtmax [mmHg/s] 9640 ±786 6663 ±325∗ 9415 ±637 3422 ±202∗∗††
Ves [μL] 28 ±23 1 ±32 6 ±24 7 ±5∗†
Diastolic function
Ped [mmHg] 4.0 ±0.81 1 .0 ±1.2∗ 3.7 ±0.31 8 .7 ±3.0∗†
dP/dtmin [mmHg/s] −7873 ±319 −4757 ±240∗∗ −7813 ±131 −2818 ±216∗∗††
Tau [ms] 11.7 ±0.31 5 .2 ±0.4∗ 11.3 ±0.71 7 .8 ±0.8∗∗†
Ved [μL] 49 ±55 7 ±34 8 ±37 4 ±4∗∗††
∗Signiﬁcantly diﬀerent versus respective control.
†Signiﬁcantly diﬀerent versus WT-CVB3.
3.7.ExtracellularMatrixAlteration. Regardingtheregulation
of extracellular matrix cryosections of cardiac tissue from
CVB3 infected and not infected mice were stained with
antibodies directed against collagen I or collagen III.
No increased area fraction of collagen III was determined
10 or 28 days after infection, whereas collagen I deposition
in the cardiac tissue was induced by CVB3. 10 days after
infection, signiﬁcantly increased collagen I content was
measured in both infected WT (3.45±0.66 fold, P = 0.0043)
and infected STAT3 KO mice (3.79 ± 1.00 fold, P = 0.0006).
Interestingly, 28 days after infection, the collagen I content
in infected WT mice (1.24 ± 0.27 fold) was reduced to the
collagen I level comparably to non infected control animals.
Whereas, this reduced collagen I content could not be
detected in infected STAT3 KO mice 28 days after infection.
There, the area fraction of collagen I was still signiﬁcantly
increased by 5.88 ± 1.82 fold compared to the untreated
controls which revealed a signiﬁcant diﬀerence between
infected WT and infected STAT3 KO mice (P = 0.0014).
Furthermore, the Col I/ColIII ratio displays a CVB3-induced
increase 10 days after infection. In WT mice, this increase
dropped signiﬁcantly down to the normal level 28 days after
infection, whereas, in infected STAT3 KO mice, the CVB3-
induced increase remains unchanged 28 days after infection
which reveals a signiﬁcant distinction (P = 0.0077) between
infected WT and infected STAT3 KO mice (Figure 5(a)).
Consequently, CVB3 infection resulted in increased ﬁbrosis
in STAT3 KO compared to WT mice.
Additionally, we further examined the mRNA expression
levels of the ECM-degrading system. The mRNA expression
of the collagenase MMP13 was not signiﬁcantly increased
10 days after infection, whereas the expression of the
endogenous inhibitor TIMP1 was signiﬁcantly increased
(WT:37.42±17.78fold,P = 0.0043;STAT3KO:51.59±28.97
fold, P<0.0001) which is then reduced to an only slightly
increased expression 28 days after infection (WT: 3.07±0.93
fold, P = 0.2168; STAT3 KO: 4.47 ± 1.54 fold, P = 0.0485)
and revealed no distinction between WT and STAT3 KO
mice.Incontrast,themRNAexpressionofMMP13inSTAT3
KO mice is signiﬁcantly reduced (0.39 ± 0.08 fold, P =
0.0121) 28 days after CVB3 infection, whereas the MMP13
expression in infected WT mice remains unchanged.
Concerning the MMP13/TIMP1 ratio, the CVB3-
induced signiﬁcant reduction of ECM degradation is clearly
demonstrated for WT and STAT3 KO mice 10 days after
infection but revealed no diﬀerence between both. Interest-
ingly, this inhibition of ECM degradation was still demon-
strated in infected STAT3 KO mice 28 days afterinfection but
was not longer determined in infected WT animals.
4. Discussion
To study the relevance of the signal transducer and activator
of transcription molecule 3 (STAT3) in CVB3-induced
myocarditis, we examined mice with a cardiomyocyte-
restricted STAT3 deletion. We show for the ﬁrst time that
STAT3 KO induces adverse cardiac remodelling leading to
DCM in the subacute phase of viral myocarditis, while no
change was seen in the acute phase when cardiomyocyte-
restricted STAT3 KO was compared to wild-type. This was
interestingly associated with increased cardiac inﬂamma-
tion followed by an exaggerated remodelling process in
cardiomyocyte-restricted STAT3 KO mice and deregulating
the matrix degradation system.
Acute CVB3 infection leads to a robust inﬂammation in
cardiac tissue of wildtype mice, which is demonstrated byCardiology Research and Practice 7
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Figure 3: VCAM expression in cardiac tissue of CVB3 infected
mice. The expression level was examined at cryosections of control
or infected mice. The expression is shown as area fraction and was
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high numbers of inﬁltrated inﬂammatory cells and highly
increased expression of proinﬂammatory cytokines such as
IL-1β,I L - 6 ,a n dT N F - α 10 days after infection [1, 19, 20]. It
is previously described for the mouse strain C57/BL6j that
the virus does not induce a chronic ongoing inﬂammation
[20]andanimalsrecoverfrommyocarditis.Inlinewiththese
ﬁndings, the wild-type animals show a reduced number of
invaded cells and decreased mRNA expression of cytokines
28 days after viral infection. Furthermore, nearly a com-
plete virus clearance was detected 28 days after infection.
Controlling inﬂammation therefore was associated with no
adverse cardiac remodelling which can be demonstrated
by no collagen accumulation as well as nearly normal LV
function 28 day after infection in wild-type animals.
STAT3 is well known as a transcription activator of IL-6
[21, 22]. Since the STAT3 KO is restricted to cardiomyocytes
[14], in cardiac tissue of infected STAT3 KO mice, a
highly upregulated IL-6 expression was detected due to the
inﬁltration of inﬂammatory cells still expressing STAT3 in
thisanimalmodel.Comparedtotheinfectedwild-typemice,
the mRNA expression levels of IL-1β,I L - 6 ,a n dT N F - α as
well as the number of inﬁltrating immune cells revealed
no distinction in STAT3 KO mice 10 days after infection.
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Figure 4: ANF expression in cardiac tissue of CVB3 infected
mice. The mRNA expression level is shown 10 and 28 days after
CVB3 infection of WT and STAT3 KO mice. The expression
data are normalized to the house-keeping gene 18S and to the
expressionlevelsofthecorrespondinguntreatedmiceandexpressed
as x-fold over basal expression using the formula 2−ΔΔCt. ∗Data
were compared to the expression of the corresponding untreated
controls. ∗P<0.05; ∗∗P<0.01. §Data between WT and STAT3 KO
mice were compared. §P<0.05.
While inﬂammation was controlled and therefore resolved
in wild-type animals between day 10 and 28, in STAT3 KO
mice, the number of invaded Mac3+ cells was not reduced
signiﬁcantly after the acute phase despite viral genome was
also extinguished. The ﬁnding that endothelial activation
demonstrated as increased vascular cell adhesion molecule
(VCAM) expression level on endothelial cells in cardiac
tissue of STAT3 KO mice is increased accommodates with
the unchanged number of inﬁltrated Mac3+ cells found 28
days after infection. The speciﬁc eﬀects of cardiomyocyte-
restricted STAT3 KO on endothelial VCAM expression levels
have to be revealed in future studies, but it is intriguing to
speculate that altered myocyte to endothelial crosstalk may
be involved in this upregulation of VCAM and therefore fuel
cardiac inﬂammation.
The previously reported characterisation of the
cardiomyocyte-restricted STAT3 KO mice in comparison
to wild-type mice revealed development of cardiac ﬁbrosis
in aging KO mice which was associated with the impaired
cardiac function [14, 15]. Left ventricles of aging wild-types
and STAT3 KO reveal an increased expression of proﬁbrotic
genes such as collagen-Iα1, connective tissue growth factor
(CTGF), and TIMP1 which could be the reason for the
age-dependent interstitial ﬁbrosis [14]. Here, 10 days after
CVB3 infection the wild-type and STAT3 KO animals
revealed a similar increase of interstitial collagen I in cardiac
tissue, whereas the amount of collagen III was not aﬀected
by CVB3 resulting in an increased Col I/Col III ratio. This
reveals that cardiac inﬂammation which controls cardiac8 Cardiology Research and Practice
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Figure 5: Collagen expression and expression of the ECM degrading system in cardiac tissue of CVB3-infected mice. The area fractions of
collagenIandcollagenIIIareshown10and28daysafterCVB3infectionofWTandSTAT3KOmiceasx-foldcomparedtothecorresponding
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remodelling was not diﬀerently regulated in the acute phase
of myocarditis in this animal model.
However, this increased Col I/Col III ratio declined
to normal levels in infected wild-type mice 28 days after
infection. In contrast, in STAT3 KO mice the CVB3 infection
resultedinaColI/ColIIIratiostillbeingupregulatedafter28
days. This ongoing ﬁbrosis in infected STAT3 KO resulted in
impairedcardiacfunction,sincecollagenisknowntodepress
cardiacfunctioninexperimentalmodelsaswellasinpatients
with cardiomyopathies [23, 24].
To further investigate the distinct mechanisms of this
changed remodelling in response to inﬂammation, we inves-
tigated the regulation of the matrix degradation system [25].
In the acute phase, an increased expression of TIMP1,
which is an endogenous inhibitor of the ECM-degrading
matrix metalloproteinases [26, 27], prevents collagen degra-
dation and thus revealed matrix deposition in both wild-
type and STAT3 KO mice 10 days after infection. One of
the most abundant matrix metalloproteases in the cardiac
tissue is the collagenase MMP13. Interestingly, reduced
MMP13 expression found in infected STAT3 KO mice 28
days after infection is consistent with the increased collagen
I protein content in infected STAT3 KO mice 28 days after
infection. The deposition and degradation of ECM is a
ﬁnely balanced equilibrium between the degrading enzymes
and their endogenous inhibitors [28, 29]. To clarify the
ECM degradation activity in the infected cardiac tissue,
the MMP13/TIMP1 ratio reveals a signiﬁcantly reduced
degradation activity in infected STAT3 KO mice 28 days
after infection compared to the infected wild-type animals.
Concerning the inﬂuence of the cardiomyocyte-restricted
STAT3 KO on the regulation of ECM, it could be assumed
thatcardiomyocytesreleaseparacrinefactorstoinﬂuencethe
ECM regulation. The presence of those paracrine factors was
conﬁrmed by the ﬁnding that the cell culture supernatant
of isolated cardiomyocytes from STAT3 KO animals induced
a higher ﬁbroblast proliferation compared with wild-type
cardiomyocytes supernatant, as shown earlier [14]. Since
cardiacﬁbroblastsarethemostprominentproducersofECM
proteins as well as of the ECM degradation system, the
paracrine eﬀects shown for ﬁbroblast proliferation can also
beassumedforregulationofECMdepositionordegradation
by cardiac ﬁbroblasts [30–33].
Conventional knockout of the STAT3 gene leads to
embryoniclethalityatembryonicday6.5[13].Therefore,the
cardiomyocyte-restrictedKOwaschosentostudytheprotec-
tive function of STAT3 against CVB3-induced myocarditis
in vivo. It has already been shown that the IL-6 cytokine
family using the Jak/STAT pathway protects cardiomyocytes
from apoptotic cell death in response to serum starvation
or ischemia and induces hypertrophy in cardiomyocytes
[34, 35]. In previous studies, the cardiac function of the
cardiomyocyte-restricted STAT3 KO mice has been analysed.
At a young age, the cardiac structure and function are
apparently normal but an age-related increase in cardiac
apoptosis and ﬁbrosis has been described [14, 15]. The
cardiomyocyte-restricteddeletionofreceptorsubunitgp130,
which also prevents STAT3 signalling, also leads to a dilated
ventricle after pressure overload [36].
In the present study, we used CVB3 to induce heart
failure. The hemodynamic characterisation clearly shows
a signiﬁcantly reduced cardiac function of CVB3-infected
STAT3 KO mice compared to CVB3-infected wild-type mice
28 days after infection. These ﬁndings are in line with the
described cardiac dysfunction of cardiomyocyte-restricted
STAT3 KO mice after myocardial infarction or doxorubicin-
induced cardiomyopathy [14, 15]. After myocardial infarc-
tion, the KO mice revealed a larger infarct size as well as a
more pronounced deterioration in systolic dysfunction [14].
In another study, they demonstrated that animals with the
cardiomyocyte-restricted STAT3 KO are more susceptible
to doxorubicin-induced cardiac injury and develop heart
failure. Thus, STAT3 deletion leads to impaired cardiac func-
tion after myocardial infarction and doxorubicin-induced
cardiomyopathy. Here, we demonstrate for the ﬁrst time that
STAT3 deletion also leads to an aggravated cardiac func-
tion in viral myocarditis induced by CVB3. Furthermore,
the cardiac-speciﬁc overexpression of STAT3 in transgenic
mice protected against doxorubicin-induced apoptosis and
therefore is another evidence that STAT3 may protect hearts
from injuries caused by diﬀerent stressors [37].
In conclusion, the present study revealed new insights
in the protective function of STAT3 expressed in car-
diomyocytes after CVB3-induced myocarditis. There and
in other cardiac damages such as myocardial infarction or
doxorubicin-induced cardiomyopathy, STAT3 in cardiomy-
ocytespreventsuncontrolledﬁbrosisandclinicalprogression
toDCM.Therefore,STAT3seemstobeacrucialfactorforthe
resolution of viral myocarditis.
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